Literature DB >> 13892932

The incorporation of C14 from uniformly labeled glucose into plasma triglycerides in normals and hyperglyceridemics.

M FINE, G MICHAELS, S SHAH, B CHAI, G FUKAYAMA, L KINSELL.   

Abstract

Entities:  

Keywords:  BLOOD SUGAR/metabolism; LIPIDS/blood

Mesh：

Substances：

Year:  1962        PMID： 13892932

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  6 in total

1.  [Quantitative studies on the incorporation of C14 plasma glucose into plasma triglycerides and on the esterification rate of plasma free fatty acids into plasma triglycerides during oral administration of glucose in primary carbohydrate-induced hypertriglyceridemia].

Authors:  F Sandhofer; K Bolzano; S Sailer; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1969-10-15

2.  [On the determination of incorporation of plasma glucose-carbon in plasma triglycerides in man].

Authors:  F Sandhofer; K Bolzano; S Sailer; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1968-11-01

3.  [Use of plasma glucose carbon in the formation of plasma triglyceride-glycerol in patients with primary "carbohydrate induced" hypertriglyceridemia].

Authors:  F Sandhofer; K Bolzano; S Sailer; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1968-10-01

4.  Effects of intravenously administered fructose and glucose on splanchnic amino acid and carbohydrate metabolism in hypertriglyceridemic men.

Authors:  B M Wolfe; S P Ahuja; E B Marliss
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

5.  Interrelations in the oxidative metabolism of free fatty acids, glucose, and glycerol in normal and hyperlipemic patients. A compartmental model.

Authors:  C L Malmendier; C Delcroix; M Berman
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

6.  Transport of plasma free fatty acids and triglycerides in man: a theoretical analysis.

Authors:  D M Shames; A Frank; D Steinberg; M Berman
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.